您当前的位置:
首页 >
文章列表页 >
Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors
Medical Journal of Chinese People′s Liberation Army   Vol. 50, Issue 3, Pages: 277-283(2025)
Special Issue on Role of Gut Microbiota in Disease Occurrence and Treatment | 更新时间:2025-04-18
    • Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors

    • In the field of gastrointestinal stromal tumor treatment, experts have explored the correlation between gut microbiota and tumor drug resistance, providing new ideas for clinical treatment.
    • DOI:10.11855/j.issn.0577-7402.0056.2024.0620    

      CLC: R735
    • Received:14 January 2024

      Accepted:2024-04-12

      Published:28 March 2025

    移动端阅览

  • Li Hao-Lin,Wang Shu,Zhao Yan,et al.Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors[J].Medical Journal of Chinese People′s Liberation Army,2025,50(03):277-283. DOI: 10.11855/j.issn.0577-7402.0056.2024.0620.

  •  
  •  

0

Views

4

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Analysis of drug resistance in disseminated pulmonary tuberculosis: 71 cases report
Clinical characteristics and drug resistance of lower respiratory tract infection with Streptococcus pneumoniae
Effect of Huaier on reversing the drug resistance of CEM-C1 cells in human acute T lymphoblastic leukemia and its mechanism

Related Author

Yang Jian-Jun
Zhao Yan
Wang Shu
Li Hao-lin
Yan Jun
Shi Yi-Heng
Wang Chao-Hong
Yang Bin

Related Institution

The Fifth Cadet Brigade of School of Basic Medicine, Air Force Military Medical University
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital of Digestive Diseases, Air Force Military Medical University
Department of Digestive Surgery, Xijing Hospital of Digestive Diseases/the First Affiliated Hospital of Air Force Military Medical University
Department of Clinical Laboratory, Beijing Chest Hospital of Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Institute
Department of Clinical Laboratory, Beijing Chest Hospital of Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Institue
0